# Comparison of ATG to Thymoglobuline in Renal Transplantation

> **NCT00861536** · PHASE4 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 40 (actual)

## Conditions studied

- Transplantation, Kidney

## Interventions

- **DRUG:** ATG Fresenius
- **DRUG:** Thymoglobuline Genzyme

## Key facts

- **NCT ID:** NCT00861536
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2015-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00861536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00861536, "Comparison of ATG to Thymoglobuline in Renal Transplantation". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00861536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*